IRCT20190406043182N1已完成3 期
The effect of Allopurinol in prevention of contrast induced nephropathy in patients undergoing angioplasty
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55 years 至 no limit（—）
- 性别
- All
入选标准
- •inclusion criteria: 1. Age> 55,2. The first turn of angioplasty3. Elective angioplasty4. Creatinine> 1 mg / kg5. Normal GFR Out put
排除标准
- •1. Emergency Angioplasty,2. Diabetes3. History of the ARF4. Chronic renal failure5. Family history of kidney disease
研究者
相似试验
已完成
2 期
Allopurinol in the prevention of pre-procedural myocardial injury following angioplastyIschemic heart diseases patients.Ischaemic heart diseasesI20, I21,IRCT201412088307N11Vice chancellor for research, Tabriz University of Medical Sciences100
已完成
不适用
Effect of allopurinol in preventing kidney damage due to coronary angiographycontrast induced nephropathy.X-ray contrast mediaIRCT2015120525372N1Tehran University of Medical Sciences200
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
招募中
3 期
CeRebrUm and CardIac protection with Allopurinol in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass100103941000751010010335Brain injuryNL-OMON52736niversitair Medisch Centrum Utrecht236
招募中
3 期
CeRebrUm and CardIac protection with ALlopurinol in Neonates with Critical Congenital Heart Disease requiring Cardiac Surgery with Cardiopulmonary Bypass2024-513041-37-00Universitair Medisch Centrum Utrecht236